doi: 10.1161/CIRCULATIONAHA.105.558676
(Circulation. 2005;112:2017-2021.)
© 2005 American Heart Association, Inc.
Preventive Cardiology |
Simple Risk Stratification at Admission to Identify Patients With Reduced Mortality From Primary Angioplasty
From the Department of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen (J.J.T., M.G.L., L.K., H.K.); Department of Medical Research, Funen Hospital, Svendborg (D.E.H.); UNI-C, Danish Information Technology Centre for Education and Research, Aarhus, Denmark (L.S.M.); and Department of Cardiology, Aarhus University Hospital, Skejby Hospital, Aarhus (H.R.A., T.T.N.), Denmark.
Correspondence to Jens Jakob Thune, MD, Department of Cardiology, B2141, University Hospital of Copenhagen, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. E-mail jjt{at}heart.dk
Received May 1, 2005; revision received July 6, 2005; accepted July 11, 2005.
Background— Randomized trials comparing fibrinolysis with primary angioplasty for acute ST-elevation myocardial infarction have demonstrated a beneficial effect of primary angioplasty on the combined end point of death, reinfarction, and disabling stroke but not on all-cause death. Identifying a patient group with reduced mortality from an invasive strategy would be important for early triage. The Thrombolysis in Myocardial Infarction (TIMI) risk score is a simple validated integer score that makes it possible to identify high-risk patients on admission to hospital. We hypothesized that a high-risk group might have a reduced mortality with an invasive strategy.
Methods and Results— We classified 1527 patients from the Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) trial with information for all variables necessary for calculating the TIMI risk score as low risk (TIMI risk score, 0 to 4) or high risk (TIMI risk score 
5) and investigated the effect of primary angioplasty versus fibrinolysis on mortality and morbidity in the 2 groups. Follow-up was 3 years. We classified 1134 patients as low risk and 393 as high risk. There was a significant interaction between risk status and effect of primary angioplasty (P=0.008). In the low-risk group, there was no difference in mortality (primary angioplasty, 8.0%; fibrinolysis, 5.6%; P=0.11); in the high-risk group, there was a significant reduction in mortality with primary angioplasty (25.3% versus 36.2%; P=0.02).
Conclusions— Risk stratification at admission based on the TIMI risk score identifies a group of high-risk patients who have a significantly reduced mortality with an invasive strategy of primary angioplasty.
Key Words: angioplasty • fibrinolysis • mortality • myocardial infarction
This article has been cited by other articles:
 |
|
 |
|
  P. W. Armstrong, C. M. Westerhout, and R. C. Welsh Duration of Symptoms Is the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction Circulation, March 10, 2009; 119(9): 1293 - 1303. [Full Text] [PDF]
|
|
|
|
|
|
P. Bogaty Duration of Symptoms Is Not Always the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction Circulation, March 10, 2009; 119(9): 1304 - 1310. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Flesch, J. Hagemeister, H.-J. Berger, A. Schiefer, S. Schynkowski, M. Klein, S. Sahebdjami, S. vom Dahl, W. Fehske, R. Mies, et al. Implementation of Guidelines for the Treatment of Acute ST-Elevation Myocardial Infarction: The Cologne Infarction Model Registry Circ Cardiovasc Intervent, October 1, 2008; 1(2): 95 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Nallamothu, R. A. Hayward, and E. R. Bates Beyond the Randomized Clinical Trial: The Role of Effectiveness Studies in Evaluating Cardiovascular Therapies Circulation, September 16, 2008; 118(12): 1294 - 1303. [Full Text] [PDF]
|
|
|
|
|
|
E. R. Bates and B. K. Nallamothu Commentary: The Role of Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction Circulation, July 29, 2008; 118(5): 567 - 573. [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Lindholm, S. Boesgaard, J. J. Thune, H. Kelbaek, H. R. Andersen, L. Kober, and DANAMI-2 investigators Percutaneous coronary intervention for acute MI does not prevent in-hospital development of cardiogenic shock compared to fibrinolysis Eur J Heart Fail, July 1, 2008; 10(7): 668 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Melandri Letter by Melandri Regarding Article, "A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction" Circulation, May 6, 2008; 117(18): e328 - e328. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Eskola, L. Holmvang, K. C. Nikus, S. Sclarovsky, H.-H. Tilsted, H. Huhtala, K. O. Niemela, and P. Clemmensen The electrocardiographic window of opportunity to treat vs. the different evolving stages of ST-elevation myocardial infarction: correlation with therapeutic approach, coronary anatomy, and outcome in the DANAMI-2 trial Eur. Heart J., December 2, 2007; 28(24): 2985 - 2991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kasapis and B. K. Nallamothu Use of the electrocardiogram in optimizing reperfusion for ST-elevation myocardial infarction: a new role for an old tool? Eur. Heart J., December 2, 2007; 28(24): 2957 - 2959. [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Nallamothu, E. H. Bradley, and H. M. Krumholz Time to Treatment in Primary Percutaneous Coronary Intervention N. Engl. J. Med., October 18, 2007; 357(16): 1631 - 1638. [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Kent and R. A. Hayward Limitations of Applying Summary Results of Clinical Trials to Individual Patients: The Need for Risk Stratification JAMA, September 12, 2007; 298(10): 1209 - 1212. [Full Text] [PDF]
|
|
|
|
|
|
K. P. Alexander, L. K. Newby, P. W. Armstrong, C. P. Cannon, W. B. Gibler, M. W. Rich, F. Van de Werf, H. D. White, W. D. Weaver, M. D. Naylor, et al. Acute Coronary Care in the Elderly, Part II: ST-Segment-Elevation Myocardial Infarction: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology Circulation, May 15, 2007; 115(19): 2570 - 2589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Keeley and L. D. Hillis Primary PCI for Myocardial Infarction with ST-Segment Elevation N. Engl. J. Med., January 4, 2007; 356(1): 47 - 54. [Full Text] [PDF]
|
|
|
|
 |
|
 M Sejersten, Y Birnbaum, R S Ripa, C Maynard, G S Wagner, P Clemmensen, and for the DANAMI-2 Investigators Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial Heart, November 1, 2006; 92(11): 1577 - 1582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Rathore, A. J. Epstein, B. K. Nallamothu, and H. M. Krumholz Regionalization of ST-Segment Elevation Acute Coronary Syndromes Care: Putting a National Policy in Proper Perspective J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1346 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Nallamothu, E. R. Bates, Y. Wang, E. H. Bradley, and H. M. Krumholz Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States: Implications for Prehospital Triage of Patients With ST-Elevation Myocardial Infarction Circulation, March 7, 2006; 113(9): 1189 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Angioplasty prolongs survival in high risk patients with confirmed heart attack BMJ, December 17, 2005; 331(7530): . [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Bassand, N. Danchin, G. Filippatos, A. Gitt, C. Hamm, S. Silber, M. Tubaro, and F. Weidinger Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology Eur. Heart J., December 2, 2005; 26(24): 2733 - 2741. [Abstract] [Full Text] [PDF]
|
|